Log In
BCIQ
Print this Print this
 

anti-BACE1/anti-TfR

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionBispecific human mAb with low-affinity against transferrin receptor and high-affinity against BACE1
Molecular Target Beta-site APP-cleaving enzyme 1 (BACE1) ; Transferrin receptor (TFRC) (TFR)
Mechanism of ActionBeta-site APP-cleaving enzyme 1 (BACE1) inhibitor; Antibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today